Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 3 of 15

 
 

Sanofi (NASDAQ:SNY)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
2 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$57.50 (11.2% Upside)

About Sanofi

Sanofi logoSanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/17/2024CitigroupUpgradeStrong-Buy
7/26/2024ArgusBoost Price TargetBuy ➝ Buy$55.00 ➝ $60.00
1/23/2024Morgan StanleyInitiated CoverageEqual Weight$55.00
12/5/2023JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
10/30/2023Stifel NicolausDowngradeBuy ➝ Hold
9/5/2023Berenberg BankUpgradeHold ➝ Buy
7/14/2023HSBCInitiated CoverageBuy
4/28/2023Deutsche Bank AktiengesellschaftDowngradeHold ➝ Sell
3/27/2023ArgusBoost Price TargetBuy$55.00 ➝ $60.00
3/27/2023BarclaysUpgradeEqual Weight ➝ Overweight
 

5 Stocks Under $5 (Ad)

Ready to discover some hidden gems in the stock market? We’ve put together a report of 5 stocks under $5 with huge potential. Whether you’re looking for value or growth, these stocks have the potential to help you make your next winning investment.

[Download Your Free Report Here]